Clinical Trial Update: Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination of sirolimus, gemcitabine, and cisplatin in patients at high risk for cholangiocarcinoma recurrence following liver trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Rapamune (sirolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Hepatic Complication | Phase 1 | Status: COMPLETED